🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

‼️🚨Attention MS4s interested in Rad Onc! Spots are filling up fast for away rotations RadOncUH ⭐️Come join us! Apply through VSLO here (or with the QR!)👉🏼👉🏼  tinyurl.com/ytfua22f, using program code RAON 4002A! Supporting grants are available! 👉🏼👉🏼tinyurl.com/6esfmm5e

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials ascopubs.org/doi/abs/10.120… This study validates a novel

Next week 4/29 is the first in our series on financial principles for #radonc! Drs. Nicholas Zaorsky, MD MS & Austin Sim, MD JD will discuss planning your financial future. Don't miss this exciting collaboration between ACRO - American College of Radiation Oncology, ARS ROCKET🚀 & ASTRO! Register: americanradiumsociety.org/page/ROCKETWeb…

Way to go ⁦University Hospitals⁩ Seidman Cancer Center! #2 is raised funds for ⁦PanCAN⁩

🎧📻To all my GI peeps, take a listen to the latest NRG Oncology podcast episode featuring Karyn Goodman, MD, MS and Ross Abrams if you want to hear a great take on history of pancreas cancer research and all things #RTOG0848 👉🏼Spotify: ow.ly/IjOh50VHVCo 👉🏼🍎: ow.ly/5PQm50VHVCs

Epidemiology of carcinomatosis pubmed.ncbi.nlm.nih.gov/40273737/ Via Cancer Epidemiology Kyle Mani Eric Lehrer, MD Lauren Henke, MD, MSCI Ming Wang_CWRU Richard Hoehn University Hospitals CWRU School of Medicine

Across the nation, thousands came together in a powerful show of support for people with pancreatic cancer and their families. PanCAN , Here is our team from University Hospitals Seidman Cancer Center RadOncUH

We are delighted to announce that Dr. Lauren Henke, MD, MSCI will be speaking at the GI session endorsed by ASTRO during the 7th annual conference of #SARO.

Great to join Lauren Henke, MD, MSCI & Ali Hosni in the ASTRO endorsed session at SARO 2025🇸🇦 — one of the most engaging sessions! I spoke on RT in pancreatic cancer & shared exciting Phase I/II trials at Loyola Medicine Grateful to ASTRO & SARO for this global platform.

Very much enjoyed making this talk. Clearly a lot of levity in it, but we do need to embrace improved tools and shape the landscape of treatment around those new tools. High risk localized, BCR, mHSPC, and even mCRPC wildly more favorable prognosis than previously when using

Exciting times at Loyola Medicine as we prepare to launch our CT-based Adaptive RT program! Grateful to lead an amazing team. Thanks to Daniel E Spratt & Lauren Henke, MD, MSCI & the wonderful team at RadOncUH for a great visit! Thanks to William Small Jr. for the leadership & support.

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Wonderful hosting you all RadOncUH at UH Seidman Cancer Center. Amazing team you have! Exciting times for adaptive RT. Dr. Theodoros Teknos Daniel I. Simon, M.D.

Angela Jia, MD, PhD Angela Jia is presenting at #ASCO25! Her work spans prostate cancer therapies, including the METANOVA trial and improving treatment selection in localized disease. Don’t miss her oral and poster sessions! RadOncUH

🚨🏳️‍🌈: Just in time for #Pride2025, our team of global researchers & LGBTQIA2+ advocates published in The Lancet Global Health on the challenges of accessing oncologic care for SGM pops across diff geosociopolitical landscapes and actionable recommendations to advance cancer equity Edward Christopher "Chris" Dee, MD

This is a great thread from Daniel E Spratt from RadOncUH CWRU School of Medicine. He is chair of National Comprehensive Cancer Network (NCCN) prostate cancer panel. He gives a summary of #USPSTF guideline changes in 2012 and 2018 and their impact older men with #ProstateCancer ASTRO #radonc

Congrats to Haley K. Perlow, MD and team!

Proud of our top-of-the-line #AdaptiveRT team! We’re lucky to have Alex Price & Lauren Henke, MD, MSCI leading the way and sharing their expertise, as well as the support of Daniel E Spratt and Rojano Kashani 💪🏼Thanks also to Varian for your partnership!

Proud Chair moment. The incredible Angela Jia representing RadOncUH on the big stage of #asco25 as the discussant to two big hitting presentations ASCO Thoughtful analysis of benefit (or not of) intraprostatic immune modulating viral therapy and the role of MMAI in

Another proud RadOncUH Chair moment to see our soon to be newest faculty SOUMYAJIT ROY being recognized for his statistical brilliance in collaboration with #IRONMAN #ASCO25 ASCO Way to go! Jason Brown Pedro C Barata, MD MSc FACP Jonathan Evan Shoag 🇮🇱🇺🇸 Lee Ponsky JAGarciaMD Dr. Theodoros Teknos